Transchem
New to Zerodha? Sign-up for free.
New to Zerodha? Sign-up for free.
Get instant stock alerts
- Share Price
- Financials
- Revenue mix
- Shareholdings
- Peers
- Forensics
Share Price
Coming soon
- 5D
- 1M
- 6M
- YTD
- 1Y
- 5Y
- MAX
Financials
-
Summary
-
Profit & Loss
-
Balance sheet
-
Cashflow
This data is currently unavailable for this company.
| (In Cr.) |
|---|
| (In Cr.) | ||||
|---|---|---|---|---|
|
This data is currently unavailable for this company. |
| (In %) |
|---|
| (In Cr.) |
|---|
| Financial Year (In Cr.) |
|---|
Revenue mix
-
Product wise
-
Location wise
Revenue Mix
This data is currently unavailable for this company.
Revenue Mix
This data is currently unavailable for this company.
Forensics
Recent events
-
News
-
Corporate Actions
Transchem acquired 100% of Greshma Shares and Stocks Limited on August 17 for ₹25.91 crore in cash, making the stock-broking company a wholly owned subsidiary. GSSL was a member of the NSE and BSE and a CDSL depository participant, with activities spanning equity and derivatives trading, IPO and mutual-fund distribution and packaged financial solutions. GSSL reported turnover of ₹5.98 crore and net worth of ₹21.32 crore at March 31, 2026, compared with turnover of ₹11.32 crore a year earlier. Transchem’s board had given in-principle approval for the acquisition in October 2025, subject to definitive agreements and regulatory clearances.
Powered by Tijori
Transchem acquired 100% of Greshma Shares and Stocks Limited on August 17 for ₹25.91 crore in cash, making the stock-broking company a wholly owned subsidiary. GSSL was a member of the NSE and BSE and a CDSL depository participant, with activities spanning equity and derivatives trading, IPO and mutual-fund distribution and packaged financial solutions. GSSL reported turnover of ₹5.98 crore and net worth of ₹21.32 crore at March 31, 2026, compared with turnover of ₹11.32 crore a year earlier. Transchem’s board had given in-principle approval for the acquisition in October 2025, subject to definitive agreements and regulatory clearances.
Powered by Tijori
Transchem completed its acquisition of 100% of Greshma Shares and Stocks Limited on August 17, paying ₹25.91 crore in cash for 1.55 crore shares. GSSL consequently became a wholly owned subsidiary. GSSL is a stockbroker on the NSE and BSE and a CDSL depository participant, offering equity and derivative trading, IPO and mutual-fund distribution, ETFs and packaged financial solutions. Transchem had reported no operating revenue in FY26 or Q1 FY27 as it reoriented its business towards financial services. GSSL's turnover was ₹5.98 crore in FY26, down from ₹11.32 crore in FY25 and ₹9.47 crore in FY24.
Powered by Tijori
Transchem completed its acquisition of 100% of Greshma Shares and Stocks Limited on August 17, paying ₹25.91 crore in cash for 1.55 crore shares. GSSL consequently became a wholly owned subsidiary. GSSL is a stockbroker on the NSE and BSE and a CDSL depository participant, offering equity and derivative trading, IPO and mutual-fund distribution, ETFs and packaged financial solutions. Transchem had reported no operating revenue in FY26 or Q1 FY27 as it reoriented its business towards financial services. GSSL's turnover was ₹5.98 crore in FY26, down from ₹11.32 crore in FY25 and ₹9.47 crore in FY24.
Powered by Tijori
- Bakkt paid USD 9.41 million to subscribe for 47,500,000 Transchem warrants under a preferential allotment.
- Transchem’s Preferential Issue Committee allotted the warrants to Bakkt Opco Holdings on June 3, 2026.
- The payment represents 25% of the total subscription amount; the warrants can be exercised into Transchem ordinary shares.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bakkt Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001628280-26-040634), on June 04, 2026, and is solely responsible for the information contained therein.
- Bakkt paid USD 9.41 million to subscribe for 47,500,000 Transchem warrants under a preferential allotment.
- Transchem’s Preferential Issue Committee allotted the warrants to Bakkt Opco Holdings on June 3, 2026.
- The payment represents 25% of the total subscription amount; the warrants can be exercised into Transchem ordinary shares.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bakkt Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001628280-26-040634), on June 04, 2026, and is solely responsible for the information contained therein.
Jan 7 (Reuters) - Transchem Ltd TRAN.BO:
CFO MUKESH GARACH RESIGNS
Source text: ID:nBSE99Q5Sz
Further company coverage: TRAN.BO
(([email protected];;))
Jan 7 (Reuters) - Transchem Ltd TRAN.BO:
CFO MUKESH GARACH RESIGNS
Source text: ID:nBSE99Q5Sz
Further company coverage: TRAN.BO
(([email protected];;))
More Nano Cap Ideas
See similar 'Nano' cap companies with recent activity
Promoter Buying
Companies where the promoters are bullish
Capex
Companies investing on expansion
Superstar Investor
Companies where well known investors have invested
Popular questions
- Business
- Financials
- Share Price
- Shareholdings
What does Transchem do?
Transchem Limited, originally focused on chemicals and pharmaceuticals, diversified into Mushroom production but due to changes in the horticulture scenario, its plant is currently non-operational.
Who are the competitors of Transchem?
Transchem major competitors are Sheetal Universal, Kotyark Industries, Mangalam Global Ent., Harrisons Malayalam, Nath Bio-Genes (I), Tierra Agrotech, SC Agrotech. Market Cap of Transchem is ₹424 Crs. While the median market cap of its peers are ₹366 Crs.
Is Transchem financially stable compared to its competitors?
Transchem seems to be less financially stable compared to its competitors. Altman Z score of Transchem is 0 and is ranked 8 out of its 8 competitors.
Does Transchem pay decent dividends?
The company seems to be paying a very low dividend. Investors need to see where the company is allocating its profits. Transchem latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%
How has Transchem allocated its funds?
Companies resources are allocated to majorly unproductive assets like Short Term Loans & Advances
How strong is Transchem balance sheet?
Transchem balance sheet is weak and might have solvency issues
Is the profitablity of Transchem improving?
The profit is oscillating. The profit of Transchem is ₹4.3 Crs for Mar 2026, ₹5.23 Crs for Mar 2025 and ₹4.2 Crs for Mar 2024
Is the debt of Transchem increasing or decreasing?
The net debt of Transchem is decreasing. Latest net debt of Transchem is -₹84.85 Crs as of Mar-26. This is less than Mar-25 when it was -₹84.68 Crs.
Is Transchem stock expensive?
Transchem is expensive when considering the PE ratio, however latest EV/EBIDTA is < 3 yr avg EV/EBIDTA. Latest PE of Transchem is 63.1, while 3 year average PE is 22.52. Also latest EV/EBITDA of Transchem is 0.0 while 3yr average is 0.71.
Has the share price of Transchem grown faster than its competition?
Transchem has given better returns compared to its competitors. Transchem has grown at ~191.04% over the last 2yrs while peers have grown at a median rate of -6.8%
Is the promoter bullish about Transchem?
Promoters stake in the company seems stable, and we need to go through filings and allocation of resources to gauge promoter bullishness. Latest quarter promoter holding in Transchem is 56.45% and last quarter promoter holding is 56.45%.
Are mutual funds buying/selling Transchem?
There is Insufficient data to gauge this.